Suchergebnisse - "Bouleftour, Wafa"

PubPharm (72)

41

Predictive resistance factors in lung cancer patients treated with Nivolumab. Retrospective study

enthalten in: Bulletin du cancer | 2021

von Bernichon, E. | Tissot, C. | Bayle-Bleuez, S. | +6

42

Vaccination and Immune Checkpoint Inhibitors : Does Vaccination Increase the Risk of Immune-related Adverse Events? A Systematic Review of Literature

enthalten in: American journal of clinical oncology | 2021

von Desage, A. | Bouleftour, W. | Rivoirard, R. | +4

43

Body surface area capping may not improve cytotoxic drugs tolerance

enthalten in: Scientific reports | 2021

von Bouleftour, W. | Viard, A. | Mery, B. | +5

44

Impact of COVID-19 Outbreak through Telemedicine Implementation on Data Reporting During Oncology Clinical Trials

enthalten in: Cancer investigation | 2021

von Bouleftour, W. | Daguenet, E. | Tinquaut, F. | +1

45

CDK 4/6 inhibitors combined with radiotherapy : A review of literature

enthalten in: Clinical and translational radiation oncology | 2021

von Bosacki, C. | Bouleftour, W. | Sotton, S. | +7

46

Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study)

enthalten in: Supportive care in cancer | 2021

von Bouleftour, W. | Muron, T. | Guillot, A. | +14

47

Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study)

enthalten in: Supportive care in cancer | 2021

von Bouleftour, W. | Muron, T. | Guillot, A. | +14

48

Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study)

enthalten in: Supportive care in cancer | 2021

von Bouleftour, W. | Muron, T. | Guillot, A. | +14

49

Effect of PARACT (PARAmedical Interventions on Patient ACTivation) on the Cancer Care Pathway : Protocol for Implementation of the Patient Activation Measure-13 Item (PAM-13) Version

enthalten in: JMIR research protocols | 2020

von Verot, E. | Bouleftour, W. | Macron, C. | +2

50

How to improve clinical research in a department of radiation oncology

enthalten in: Bulletin du cancer | 2020

von Gessen, S. | Daguenet, E. | Gras, M. | +5